Showcases Stock ranks Forex

Eli Lilly and Company (LLY)
154.17  1.7 (1.11%) 09-18 16:04
Open: 152.04 Pre. Close: 152.47
High: 154.5 Low: 152.04
Volume: 13,187,175 Market Cap: 147,459M
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 38,680 full-time employees. The firm discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The firm's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment develops, manufactures and markets products for both food animals and companion animals. The firm's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The firm's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 154.593 - 155.05 155.05 - 155.561
Low: 150.637 - 151.2 151.2 - 151.832
Close: 153.173 - 154.026 154.026 - 154.982
Stock Technical Analysis
Target: Six months: 180.46
One year: 210.77
Support: Support1: 149.07
Support2: 145.72
Resistance: Resistance1: 154.50
Resistance2: 180.46
Pivot: 149.65
Moving Averages: MA(5): 151.34
MA(20): 149.57
MA(100): 155.22
MA(250): 139.53
MACD: MACD(12,26): -0.42
Signal(12,26,9): -1.25
%K %D: %K(14,3): 79.66
%D(3): 65.22
RSI: RSI(14): 57.21
52-Week: High: 170.75
Low: 101.36
Change(%): 35.0
Average Vol(K): 3-Month: 300565
10-Days: 423255
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

LLY has closed above the upper band by 4.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 38.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 18 Sep 2020
Investors Are Craving More from Eli Lilly and Company [LLY] Stocks: Here is Why - MZP News

Thu, 17 Sep 2020
Eli Lilly and Company (LLY) Management Presents at Cantor Fitzgerald Healthcare Conference (Transcript) - Seeking Alpha

Thu, 17 Sep 2020
Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies - PRNewswire

Wed, 16 Sep 2020
Eli Lilly and Co (LLY) Presents at Morgan Stanley Global Healthcare Broker Conference Call - (Transcript) - Seeking Alpha

Wed, 09 Sep 2020
Lilly Announces Leadership Changes - PRNewswire

Sun, 06 Sep 2020
Eli Lilly’s Price Target Raised to $176 with Overweight Rating, $214 in Best Case: Morgan Stanley - Yahoo Finance

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 956.47
Shares Float (M) 743.73
% Held by Insiders 0.15
% Held by Institutions 79.61
Shares Short (K) 4660
Shares Short Prior Month (K) 4510
Stock Financials
EPS 6.150
Book Value (p.s.) 4.510
Profit Margin 24.48
Operating Margin 27.83
Return on Assets (ttm) 9.9
Return on Equity (ttm) 157.6
Qtrly Rev. Growth -2.4
Gross Profit (p.s.) 18.401
Sales Per Share 23.994
EBITDA (p.s.) 7.956
Qtrly Earnings Growth 6.40
Operating Cash Flow (M) 6350.00
Levered Free Cash Flow (M) 3770.00
Stock Valuation
PE Ratio 25.07
PEG Ratio 1.15
Price to Book value 34.18
Price to Sales 6.43
Price to Cash Flow 23.22
Stock Dividends
Dividend 2.770
Dividend Yield 0.02
Dividend Growth 2.960

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator